神经丝蛋白轻链在神经系统疾病中的研究现状
The Current Research Status of Neurofilament Light Chains in Neurological Diseases
DOI: 10.12677/acm.2024.1451648, PDF,   
作者: 高元浩, 王雨诺*：延安大学医学院，陕西 延安；张 卓：咸阳市中心医院介入科，陕西 咸阳
关键词: 神经丝蛋白；神经丝轻链；神经系统疾病；综述；Neurofilament Light Chain； Neurofilaments； Neurological Diseases； Summarize
摘要: 轴突中高度集中表达的神经元细胞内蛋白质，神经丝蛋白轻链(neurofilament light chain, NfL)，是检测轴突损害的灵敏指标。识别及定量轴突损伤对于评判神经系统病症的活跃度、追踪治疗效果以及预测疾病走向尤为关键。不同神经系统病症引起的轴突损害程度与脑脊液和血清中的神经丝蛋白轻链水平成正相关。利用新型免疫检测技术，能够在极低浓度下定量监测这些生物标志物，进而通过血液中的神经丝蛋白轻链水平来追踪疾病进程。因此，本篇文章综述了神经丝蛋白的结构与作用，并分析了其与神经系统病变之间的联系。
Abstract: The neuronal intracellular proteins that are highly expressed in axons, neurofilament light chains (NfL), are sensitive markers for the detection of axonal damage. Identifying and quantifying axonal injuries are crucial for assessing the activity of neurological diseases, monitoring therapeutic effects, and predicting disease progression. The extent of axonal damage caused by different neurological disorders correlates positively with the levels of neurofilament light chains in cerebrospinal fluid and serum. Utilizing advanced immunodetection techniques, these biomarkers can be quantitatively monitored at very low concentrations, thereby tracking the disease progression through the levels of neurofilament light chains in blood. Therefore, this article reviews the structure and function of neurofilaments and analyzes their relationship with neurological pathologies.
文章引用：高元浩, 张卓, 王雨诺. 神经丝蛋白轻链在神经系统疾病中的研究现状[J]. 临床医学进展, 2024, 14(5): 2042-2045. https://doi.org/10.12677/acm.2024.1451648

参考文献

[1] 佟向军, 陈建国, 翟中和. 神经丝的结构与功能[J]. 细胞生物学杂志, 1998(2): 63-68.
[2] Yuan, A. and Nixon, R.A. (2021) Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies. Frontiers in Neuroscience, 15, 689938. [Google Scholar] [CrossRef] [PubMed]
[3] 张群, 林思睿, 吴琼英, 等. 神经丝轻链蛋白与神经系统疾病[J]. 中风与神经疾病杂志, 2019, 36(4): 380-382. [Google Scholar] [CrossRef] 
[4] Abu-Rumeileh, S., Abdelhak, A., Foschi, M., et al. (2023) The Multifaceted Role of Neurofilament Light Chain Protein in Non-Primary Neurological Diseases. Brain, 146, 421-437. [Google Scholar] [CrossRef] [PubMed]
[5] 杨红旗, 陈生弟. 神经丝蛋白轻链在阿尔茨海默病诊断中的价值[J]. 阿尔茨海默病及相关病杂志, 2020, 3(3): 177-181 173.
[6] Gentil, B.J., Tibshirani, M. and Durham, H.D. (2015) Neurofilament Dynamics and Involvement in Neurological Disorders. Cell and Tissue Research, 360, 609-620. [Google Scholar] [CrossRef] [PubMed]
[7] Malka-Gibor, E., Kornreich, M., Laser-Azogui, A., et al. (2017) Phosphorylation-Induced Mechanical Regulation of Intrinsically Disordered Neurofilament Proteins. Biophysical Journal, 112, 892-900. [Google Scholar] [CrossRef] [PubMed]
[8] Yuan, A., Sasaki, T., Kumar, A., et al. (2012) Peripherin Is a Subunit of Peripheral Nerve Neurofilaments: Implications for Differential Vulnerability of CNS and Peripheral Nervous System Axons. Journal of Neuroscience, 32, 8501-8508. [Google Scholar] [CrossRef] 
[9] Deek, J., Chung, P.J., Kayser, J., et al. (2013) Neurofilament Sidearms Modulate Parallel and Crossed-Filament Orientations Inducing Nematic to Isotropic and Re-Entrant Birefringent Hydrogels. Nature Communications, 4, 2224. [Google Scholar] [CrossRef] [PubMed]
[10] Khalil, M., Teunissen, C.E., Otto, M., et al. (2018) Neurofilaments as Biomarkers in Neurological Disorders. Nature Reviews Neurology, 14, 577-589. [Google Scholar] [CrossRef] [PubMed]
[11] Bridel, C., van Wieringen, W.N., Zetterberg, H., et al. (2019) Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-Analysis. JAMA Neurology, 76, 1035-1048. [Google Scholar] [CrossRef] [PubMed]
[12] Oboudiyat, C., Glazer, H., Seifan, A., et al. (2013) Alzheimer’s Disease. Seminars in Neurology, 33, 313-329. [Google Scholar] [CrossRef] [PubMed]
[13] Mattsson, N., Andreasson, U., Zetterberg, H., et al. (2017) Alzheimer’s Disease Neuroimaging Initiative. Association of Plasma Neurofilament Light with Neurodegeneration in Patients with Alzheimer Disease. JAMA Neurology, 74, 557-566. [Google Scholar] [CrossRef] [PubMed]
[14] Hauser, S.L. and Cree, B.A.C. (2020) Treatment of Multiple Sclerosis: A Review. The American Journal of Medicine, 133, 1380-1390.e2. [Google Scholar] [CrossRef] [PubMed]
[15] 杨清燕, 陈涓涓, 吴军. 神经丝轻链在神经系统疾病中的研究进展[J]. 中西医结合心脑血管病杂志, 2021, 19(11): 1837-1840.
[16] Barro, C., Benkert, P., Disanto, G., et al. (2018) Serum Neurofilament as a Predictor of Disease Worsening and Brain and Spinal Cord Atrophy in Multiple Sclerosis. Brain, 141, 2382-2391. [Google Scholar] [CrossRef] [PubMed]
[17] Thebault, S., Abdoli, M., Fereshtehnejad, S.M., et al. (2020) Serum Neurofilament Light Chain Predicts Long Term Clinical Outcomes in Multiple Sclerosis. Scientific Reports, 10, 10381. [Google Scholar] [CrossRef] [PubMed]
[18] Bäckström, D., Linder, J., Jakobson, M.O., S, et al. (2020) NfL as a Biomarker for Neurodegeneration and Survival in Parkinson Disease. Neurology, 95, e827-e838. [Google Scholar] [CrossRef] 
[19] Olsson, B., Portelius, E., Cullen, N.C., et al. (2019) Association of Cerebrospinal Fluid Neurofilament Light Protein Levels with Cognition in Patients with Dementia, Motor Neuron Disease, and Movement Disorders. JAMA Neurology, 76, 318-325. [Google Scholar] [CrossRef] [PubMed]

为你推荐